col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


132 Results       Page 1

 [1] 
Elsevier: Archives of Medical Research
  original article Date Title Authors   All Authors
1 [GO] 2025―Feb―01 A retrospective cohort study on COVID-19 reinfections and associated factors during six waves of the pandemic in Mexico Iván de Jesús Ascencio-Montiel, Susana Isabel Suárez-Domínguez, Ramón Alberto Rascón-Pacheco, Alejandro Alonso-Molina, Gerardo Chowell, Célida Duque-Molina, Víctor Hugo Borja-Aburto
2 [GO] 2025―Feb―01 Engaging communities in health promotion through community-based primary care and participatory research during the COVID-19 pandemic in Bolivia Christine Leyns, Carla Ascarrunz, Shirley Rasguido, Patricia Rodriguez, Daniel Eid, Javier Guitian
3 [GO] 2025―Jan―23 Assessing Hypertension Management in Peru's Peri-Urban Community in the Wake of the COVID-19 Pandemic Laura Espinoza-Pajuelo, Patricia J. García, Jesús Medina-Ranilla, Antonio Bernabé-Ortiz, Ezequiel García-Elorrio, Hannah H. Leslie
4 [GO] 2025―Jan―06 Humoral immune response to SARS-CoV-2 vaccines in patients with autoimmune rheumatic diseases Paula María Corbalan, Rodrigo Hernán Tomas-Grau, Mariana Pera, Diego Ploper, Gabriela Vanesa Espasa, Silvia Inés Cazorla, et al. (+12)
5 [GO] 2024―Dec―22 Respiratory pathogen trends in queensland, australia between 2018 and 2021: A statewide cohort study before and after the initial COVID-19 outbreak Amy L. Sweeny, John Gerrard, Kylie Alcorn, Gary Grant, Ya-Ling Huang, Benjamin Gerhardy, Gerben Keijzers
6 [GO] 2024―Nov―29 COVID-19 in Venezuela: Costs and challenges of management severe cases at home in a crisis setting David A. Forero-Peña, Fhabián S. Carrión-Nessi, Óscar D. Omaña-Ávila, Daniela L. Mendoza-Millán, Augusto Moncada-Ortega, María E. Landaeta
7 [GO] 2024―Oct―24 Strengthening public health systems during an emerging respiratory disease pandemic: A realist review Zahra Afshar Hosseinabadi, Mostafa Amini-Rarani, Mohammadreza Amiresmaili, Nasrin Shaarbafchizadeh, Ahmad Reza Raeisi
8 [GO] 2024―Oct―15 COVID-19 policy response: Perspectives of key stakeholders in Mexico's health system and implications for resilience Lina Díaz-Castro, Christian Díaz de León-Castañeda, Galileo Pérez-Hernández, José Carlos Suárez-Herrera
9 [GO] 2024―Oct―14 Post COVID-19: Advancing medical laboratory service integration in nigeria and progress towards establishing integration guideline Augustine Onyeaghala, Nkechi Nwoke, Kingsley Odiabara, Ughweroghene Kingston Omo-Emmanuel, Jibrin Kama, Bashir Mahmud, et al. (+2)
10 [GO] 2024―Oct―05 Comment on “Serendipitous adrenal hyperplasia in patients admitted to the emergency department for suspected SARS-CoV-2 infection is linked to increased mortality” Hinpetch Daungsupawong, Viroj Wiwanitkit
11 [GO] 2024―Sep―14 How Latin American health care systems will respond to the next crises? Lessons and challenges after the COVID-19 pandemic Adolfo Rubinstein
12 [GO] 2024―Sep―10 Impact on Fatality Rates and Years of Life Lost During the COVID-19 Pandemic: The Experience of the Mexican Public Health Incident Management Command Célida Duque-Molina, Gabriel García-Rodríguez, Christian Arturo Zaragoza-Jiménez, Alethse de la Torre-Rosas, Michelle Herrera-Canales, Miriam Jackeline Loera-Rosales, et al. (+13)
13 [GO] 2024―Jul―16 Candida Isolation During COVID-19: Microbiological Findings of a Prospective Study in a Regional Hospital Jaquelin Naranjo-Bravo, Daniel Romero-Romero, Araceli Contreras-Rodríguez, Ma. Guadalupe Aguilera-Arreola, Berenice Parra-Ortega
14 [GO] 2024―Jun―15 Strengthening Essential Health Services Recovery Policy after the COVID-19 Pandemic. Evidence from the Mexican Institute of Social Security Svetlana V. Doubova, Saúl Eduardo Contreras-Sánchez, Ivan de Jesús Ascencio-Montiel, Margot González-León, Ernesto Krug-Llamas, Gabriela Borrayo-Sánchez, et al. (+4)
15 [GO] 2024―May―27 Serendipitous Adrenal Hyperplasia in Patients Admitted to the Emergency Department for Suspected SARS-CoV-2 Infection is Linked to Increased Mortality Giuseppe Reimondo, Federica Solitro, Soraya Puglisi, Maurizio Balbi, Giorgio Maria Tiranti, Anna Maria Elena Perini, et al. (+9)
16 [GO] 2024―Jan―30 De Novo Vitiligo Following Covid-19 Infection and Vaccination: A Door Open to Future Events? RAFFAELLA MORMILE
17 [GO] 2024―Jan―29 Intranasal Versus Intravenous Dexamethasone to Treat Hospitalized COVID-19 Patients: A Randomized Multicenter Clinical Trial Graciela Cárdenas, María Chávez-Canales, Ana María Espinosa, Antonio Jordán-Ríos, Daniel Anica Malagon, Manlio Fabio Márquez Murillo, et al. (+43)
18 [GO] 2023―Aug―14 Mortality Prognosis Factors in Patients with Active Cancer Under Treatment, and Severe COVID-19 Paula Cabrera-Galeana, Nancy Reynoso-Noverón, Carlos González-Nuñez, Oscar Arrieta, Juan Torres, Silvia Allende, et al. (+5)
19 [GO] 2023―Jun―21 Corrigendum to ‘Case-finding: Fast, Available, and Efficient Font-line Diagnostics for SARS-CoV-2’[Arch. Med. Res. 51(5) (2020) 453-454/ARCMED 2020 432] Farid Rahimi, Amin Talebi Bezmin Abadi
20 [GO] 2023―Mar―31 Role of FokI rs.2228570 and Tru9I rs.757343 Polymorphisms in the Mortality of Patients Infected with Different Variants of SARS-CoV-2 Hasan Rahman Shawi Shawi, Enayat Anvari, Abolfazl Fateh
21 [GO] 2023―Mar―15 Chronic Comorbidities in Middle Aged Patients Contribute to Ineffective Emergency Hematopoiesis in Covid-19 Fatal Outcomes Rubí Romo-Rodríguez, Karla Gutiérrez-de Anda, Jebea A López-Blanco, Gabriela Zamora-Herrera, Paulina Cortés-Hernández, Gerardo Santos-López, et al. (+26)
22 [GO] 2023―Feb―14 Potential Role of Vitamin D, ACE2 and the Proteases as TMPRSS2 and Furin on SARS-CoV-2 Pathogenesis and COVID-19 Severity Mesut Ortatatli, Tugba Fatsa, Tugba Fatsa, Deniz Dogan Mulazimoglu, Sema Oren, Cumhur Artuk, et al. (+3)
23 [GO] 2022―Dec―30 Serum Calcitonin Gene-Related Peptide α and β Levels are Increased in COVID-19 Inpatients Gabriel Gárate, Marta Pascual, Montserrat Rivero, María Toriello, Sara Pérez-Pereda, Vicente González-Quintanilla, et al. (+6)
24 [GO] 2022―Dec―28 Impact of TRIM5α and TRIM22 Genes Expression on the Clinical Course of Coronavirus Disease 2019 Rezvan Tavakoli, Pooneh Rahimi, Mojtaba Hamidi-Fard, Sana Eaybpoush, Delaram Doroud, Seyed Amir Sadeghi, et al. (+3)
25 [GO] 2022―Nov―03 Bioinformatic Analysis of B- and T-cell Epitopes from SARS-CoV-2 Structural Proteins and their Potential Cross-reactivity with Emerging Variants and other Human Coronaviruses Diana Laura Pacheco-Olvera, Stephanie Saint Remy-Hernández, María Guadalupe García-Valeriano, Tania Rivera-Hernández, Constantino López-Macías
26 [GO] 2022―Aug―25 Probiotics for the Management of COVID-19 Sequelae CHIA SIANG KOW, DINESH SANGARRAN RAMACHANDRAM, SYED SHAHZAD HASAN
27 [GO] 2022―Aug―23 Preliminary Genomic Analysis of the Omicron Variants of SARS-CoV-2 in Central India During the third wave of the COVID-19 Pandemic Priyanka Singh, Sanjay Singh Negi, Anudita Bhargava, Vara Prasad Kolla, Ripu Daman Arora
28 [GO] 2022―Aug―15 Response to: Regarding the Article: Probiotics in Prevention and Treatment of COVID-19: Current Perspective and Future Prospects SHILIA JACOB KURIAN, SONAL SEKHAR MIRAJ
29 [GO] 2022―Jul―08 Syndemic Nature of COVID-19 in Latin American and Caribbean Countries: The Challenge Ahead Ricardo Perez-Cuevas, Svetlana V. Doubova
30 [GO] 2022―May―25 Utility of Serum S100B as A Marker in Systemic Lupus Erythematosus Patients During and After the SARS-CoV-2 Pandemic ELENA NORIS-GARCÍA, MARIA DE LOS ANGELES ROBINSON-AGRAMONTE, CARLOS-ALBERTO GONÇALVES
31 [GO] 2022―May―25 Reply to: Utility of Serum S100B as a Marker in SLE Patients During and After the SARS-Cov-2 Pandemic SI-YU ZHOU, WEN-JING SHU, HAI-FENG PAN
32 [GO] 2022―May―17 Regarding the Article: A multimodal strategy to reduce the risk of hospitalization/death in ambulatory patients with COVID-19 SAMUEL PONCE DE LEÓN-ROSALES, LOURDES GARCÍA GARCÍA, DANIELA DE LA ROSA ZAMBONI, PATRICIO SANTILLÁN DOHERTY, MAURICIO RODRÍGUEZ-ÁLVAREZ
33 [GO] 2022―May―10 Response to: Regarding the Article: A Multimodal Strategy to Reduce the Risk of Hospitalization/death in Ambulatory Patients with COVID-19 CÉSAR RAÚL GONZALEZ BONILLA
34 [GO] 2022―May―07 Increment of D-dimer Associated with Immune Thrombotic Thrombocytopenia in ChAdOx1 nCoV-19 (AstraZeneca-Oxford) Vaccinated Individuals: A Systematic Review José Manuel Ornelas-Aguirre, Alejandro V. Gómez-Alcalá, Diego Hazael Ramírez-Leyva
35 [GO] 2022―Apr―29 Challenges for Peritoneal Dialysis Centers Before and During the COVID-19 Pandemic in Mexico Diana Perez-Moran, Ricardo Perez-Cuevas, Svetlana V. Doubova
36 [GO] 2022―Apr―18 Efficacy and Safety of Vitamin D Supplementation to Prevent COVID-19 in Frontline Healthcare Workers. A Randomized Clinical Trial Miguel A Villasis-Keever, Mardia G López-Alarcón, Guadalupe Miranda-Novales, Jessie N Zurita-Cruz, Aly S Barrada-Vázquez, Joaquín González-Ibarra, et al. (+10)
37 [GO] 2022―Mar―22 Utility of a Pulmonary Oedema Score for Predicting the Need for Mechanical Ventilation in COVID-19 Patients in a General Hospital Criseida Torres-Vargas, José Legorreta-Soberanis, Belén Madeline Sánchez-Gervacio, Pablo Alberto Fernández-López, Miguel Flores-Moreno, Víctor Manuel Alvarado-Castro, et al. (+3)
38 [GO] 2022―Mar―14 COVID-19 in Neonates with Positive RT-PCR Test. Systematic Review Heladia García, Aldo Allende-López, Paulina Morales-Ruíz, Guadalupe Miranda-Novales, Miguel Ángel Villasis-Keever
39 [GO] 2022―Jan―24 A Multimodal Strategy to Reduce the Risk of Hospitalization/death in Ambulatory Patients with COVID-19 Iván de Jesús Ascencio-Montiel, Juan Carlos Tomás-López, Verónica Álvarez-Medina, Luisa Estela Gil-Velázquez, Hortensia Vega-Vega, Héctor Raúl Vargas-Sánchez, et al. (+4)
40 [GO] 2022―Jan―19 Is Omicron the last SARS-CoV-2 Variant of Concern? Farid Rahimi, Amin Talebi Bezmin Abadi
41 [GO] 2021―Oct―18 Guillain-Barré Syndrome During the COVID-19 Pandemic and the Relationship Between Acute Phase Reactants and Disability Recep Yevgi
42 [GO] 2021―Oct―15 ORIGINAL ARTICLEVery Low Vitamin D Levels are a Strong Independent Predictor of Mortality in Hospitalized Patients with Severe COVID-19 Juan C. Ramirez-Sandoval, Valeria Jocelyne Castillos-Ávalos, Armando Paz-Cortés, Airy Santillan-Ceron, Sergio Hernandez-Jimenez, Roopa Mehta, Correa-Rotter Ricardo
43 [GO] 2021―Oct―13 Abo Blood Group, Atherothrombotic Comorbidities, and COVID-19: A Case-Control Study of their Association in the Mexican Population Jacqueline Gamboa-Aguilar, Ángela Carele Zamorano-Montaño, Aldo Enríquez-Osorio, Wendoline Torres-Cubillas, José Luis López-Arroyo, José Agustín Mata Chapol, et al. (+32)
44 [GO] 2021―Sep―06 Seroconversion in septic ICU patients presenting with COVID-19: necessary but not sufficient Filippo Conti, Guy Oriol, Valerie Cheynet, Claire Tardiveau, Elizabeth Cerrato, Thomas Rimmelé, et al. (+6)
45 [GO] 2021―Aug―13 OBESITY AND SEVERE COVID-19 IN THE YOUNG: IS DOWNREGULATION OF miR-126 A PIECE OF THE SARS-COV2 PATHOGENICITY PUZZLE? Raffaella Mormile
46 [GO] 2021―Aug―09 The Association Between Anti-diabetic Agents and Clinical Outcomes of COVID-19 in Patients with Diabetes: A Systematic Review and Meta-Analysis Tiantian Han, Shaodi Ma, Chenyu Sun, Huimei Zhang, Guangbo Qu, Yue Chen, et al. (+10)
47 [GO] 2021―Jul―30 COVID-19 vaccine guidance for patients with cancer in Mexico: report from the working group of the Mexican Society of Oncology Enrique Soto-Perez-de-Celis, Oscar Arrieta, Enrique Bargalló-Rocha, Saúl Campos-Gómez, Yanin Chavarri-Guerra, Jessica Chávez-Nogueda, et al. (+3)
48 [GO] 2021―Jul―06 COVID-19 in children: where do we stand? Georgia B. Nikolopoulou, Helena C. Maltezou
49 [GO] 2021―Jul―05 Letter to the Editor: Thromboprophylaxis strategies for COVID-19 patients Mateo Porres-Aguilar, Orlando R. Pérez-Nieto, Éder I. Zamarrón-López, Silvio A. Ñamendys-Silva
50 [GO] 2021―Jun―23 Efficacy of a Low Dose of Melatonin as an Adjunctive Therapy in Hospitalized Patients with COVID-19: A Randomized, Double-blind Clinical Trial Gholamreza Farnoosh, Mostafa Akbariqomi, Taleb Badri, Mahdi Bagheri, Morteza Izadi, Ali Saeedi-Boroujeni, et al. (+6)
51 [GO] 2021―Jun―07 The comparison of oxidative markers between Covid-19 patients and healthy subjects Fereshteh Mehri, Amir Hossein Rahbar, Elaheh Talebi Ghane, Bahram Souri, Maryam Esfahani
52 [GO] 2021―Jun―07 Quinacrine, an old drug with potential application as a treatment for novel coronavirus 2019-nCoV/SARSCoV-2 infection Benjamin Pineda
53 [GO] 2021―Jun―05 Vasoactive Peptides: Their Role in COVID-19 Pathogenesis and Potential Use as Biomarkers and Therapeutic Targets Pariya Khodabakhsh, Afsaneh Asgari Taei, Moein Mohseni, Dorsa Bahrami Zanjanbar, Hasti Khalili, Kimia Masoumi, et al. (+2)
54 [GO] 2021―May―24 Is cancer an independent risk factor for fatal outcomes of coronavirus disease 2019 patients? Jie Xu, Wenwei Xiao, Li Shi, Yadong Wang, Haiyan Yang
55 [GO] 2021―Apr―23 COVID-19 vaccine diplomacy and equitable access to vaccines amid ongoing pandemic Khan Sharun, Kuldeep Dhama
56 [GO] 2021―Apr―13 Impact of metabolic syndrome in the clinical outcome of disease by SARS-COV-2 in Mexican population José Israel León-Pedroza, Octavio Rodríguez-Cortés, Raúl Flores-Mejía, Cinthia Vianney Gaona-Aguas, Antonio González-Chávez
57 [GO] 2021―Apr―08 Emerging roles of coronavirus in autoimmune diseases Si-Yu Zhou, Chi Zhang, Wen-Jing Shu, Li-Ye Chong, Jun He, Zhiwei Xu, Hai-Feng Pan
58 [GO] 2021―Mar―26 A meta-analysis: Proton pump inhibitors current use and the risk of Coronavirus Infectious Disease 2019 development and its related mortality Ahmad Amjed Toubasi, Rand Bilal AbuAnzeh, Bann Rami Khraisat, Thuraya Nael Al-Sayegh, Saif Aldeen AlRyalat
59 [GO] 2021―Mar―20 Probiotics in Prevention and Treatment of COVID-19: Current Perspective and Future Prospects Shilia Jacob Kurian, Mazhuvancherry Kesavan Unnikrishnan, Sonal Sekhar Miraj, Debasis Bagchi, Mithu Banerjee, B Shrikar Reddy, et al. (+5)
60 [GO] 2021―Feb―10 Bioinformatics Analysis for Screening of Therapeutic Drugs in COVID-19 Pathum Sookaromdee, Viroj Wiwanitkit
61 [GO] 2021―Feb―10 Predictive value of CAR for In-Hospital Mortality in Patients with COVID-19 Pneumonia: A Retrospective Cohort Study Başak Çakır Güney, Yeşim Önal Taştan, Betül Doğantekin, Zeliha Serindağ, Murat Yeniçeri, Vedat Çiçek, et al. (+5)
62 [GO] 2021―Jan―29 Immunoinformatics approach for the identification and characterization of T cell and B cell epitopes towards the peptide-based vaccine against SARS-CoV-2 Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, Garima Sharma, Sang-Soo Lee
63 [GO] 2021―Jan―23 Remote Prescription During Pandemic: Challenges and Solutions Ee-Chien Lim, Celeste Yan-Teng Chen, Eng-King Tan
64 [GO] 2021―Jan―22 Surgical outcomes during COVID-19 pandemic in a third level social security hospital in southeast Mexico Andrea Nachon-Acosta, Gustavo Martinez-Mier, Victor Flores-Gamboa, Octavio Avila-Mercado, Indira Morales Garcia, Carlos Yoldi-Aguirre, et al. (+2)
65 [GO] 2021―Jan―22 Implications of the Emergence of a New Variant of SARS-CoV-2, VUI-202012/01 Farid Rahimi, Amin Talebi Bezmin Abadi
66 [GO] 2021―Jan―13 Response to: Regarding the Article: Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development Kevin Ita
67 [GO] 2021―Jan―13 Regarding the Article: Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development Fatemeh Mirzaei, Seyed Alireza Vafaei, Ebrahim Abbasi-oshaghi
68 [GO] 2020―Dec―23 New COVID-19 vaccines, its cost and shelf life: a cost effectiveness analysis Pathum Sookaromdee, Viroj Wiwanitkit
69 [GO] 2020―Dec―16 Hypertension, diabetes and obesity, major risk factors for death in patients with COVID-19 in Mexico. Jorge Escobedo-de la Peña, Ramón Alberto Rascón Pacheco, Iván de Jesús Ascencio-Montiel, Evangelina González-Figueroa, José Esteban Fernández-Gárate, Oswaldo Sinoé Medina-Gómez, et al. (+3)
70 [GO] 2020―Dec―16 COVID-19 Vaccines: New developments and the road ahead Kevin Ita, Monica Ukaoma
71 [GO] 2020―Dec―04 Integrated Bioinformatics Analysis for the Screening of Associated Pathways and Therapeutic Drugs in Coronavirus Disease 2019 Ting Wang, Minghui Zhao, Pingping Ye, Qian Wang, Yongshan Zhao
72 [GO] 2020―Nov―17 Potential Drug Interactions of Repurposed COVID-19 Drugs with Lung Cancer Pharmacotherapies Gayathri Baburaj, Levin Thomas, Mahadev Rao
73 [GO] 2020―Nov―17 A Shift Towards an Immature Myeloid Profile in Peripheral Blood of Critically Ill COVID-19 Patients Eduardo Vadillo, Keiko Taniguchi-Ponciano, Constantino Lopez-Macias, Roberto Carvente-Garcia, Hector Mayani, Eduardo Ferat-Osorio, et al. (+30)
74 [GO] 2020―Nov―10 Diabetes Mellitus is Associated with Severe Infection and Mortality in Patients with COVID-19: A Systematic Review and Meta-analysis Eugen Silviu Bud, Alexandru Vlasa, Anamaria Bud
75 [GO] 2020―Nov―10 An evidence-based protocol for minimising thromboembolic events in SARS-CoV-2 infection Ashok Kumar Arigondam, Abdul Rahman Hakeem, Mettu Srinivas Reddy, Mohamed Rela
76 [GO] 2020―Oct―26 Role of Systemic and Nasal Glucocorticoid Treatment in the Regulation of the Inflammatory Response in Patients with Sars-Cov-2 Infection Graciela Cárdenas, Diana Torres-García, Jaquelynne Cervantes, Sergio Rosales-Mendoza, Agnes Fleury, Gladis Fragoso, et al. (+2)
77 [GO] 2020―Oct―17 COVID-19 and Flu Pandemics Follow a Pattern: A possible Cross-immunity in the Pandemic Origin and Graver Disease in Farther Regions Alireza Bolourian, Zahra Mojtahedi
78 [GO] 2020―Oct―10 COVID-19: Clouds Over the Antimicrobial Resistance Landscape Mauricio Rodríguez-Álvarez, Yolanda López-Vidal, José Luis Soto-Hernández, María Guadalupe Miranda-Novales, Karen Flores-Moreno, Samuel Ponce de León-Rosales
79 [GO] 2020―Sep―17 Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study Krishnaprasad Baby, Swastika Maity, Chetan H. Mehta, Akhil Suresh, Usha Y. Nayak, Yogendra Nayak
80 [GO] 2020―Sep―15 Subsequent Curves of COVID-19 in Society Rodrigo Ramos-Zúñiga
81 [GO] 2020―Sep―12 Biosafety Concerns During the Collection, Transportation, and Processing of COVID-19 Samples for Diagnosis Kumaragurubaran Karthik, Ramasamy Parthiban Aravindh Babu, Kuldeep Dhama, Murugesan Ananda Chitra, Govindan Kalaiselvi, Tuticorin Maragatham Alagesan Senthilkumar, Gopal Dhinakar Raj
82 [GO] 2020―Sep―10 Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development Kevin Ita
83 [GO] 2020―Sep―09 Bioactive Lipids in COVID-19-Further Evidence Undurti N. Das
84 [GO] 2020―Aug―11 A Perspective on Erythropoietin as a Potential Adjuvant Therapy for Acute Lung Injury/Acute Respiratory Distress Syndrome in Patients with COVID-19 Adeleh Sahebnasagh, Mojataba Mojtahedzadeh, Farhad Najmeddin, Atabak Najafi, Mohammadreza Safdari, Hassan Rezai Ghaleno, et al. (+3)
85 [GO] 2020―Aug―07 Diabetes Mellitus is Associated with Severe Infection and Mortality in Patients with COVID-19: A Systematic Review and Meta-analysis Luxiang Shang, Mengjiao Shao, Qilong Guo, Jia Shi, Yang Zhao, Jiasuoer Xiaokereti, Baopeng Tang
86 [GO] 2020―Jul―23 Messaging Fatigue and Desensitisation to Information During Pandemic Philip Kheng-Keah Koh, Ling Ling Chan, Eng-King Tan
87 [GO] 2020―Jul―22 Increased Risk of Hospitalization and Death in Patients with COVID-19 and Pre-existing Noncommunicable Diseases and Modifiable Risk Factors Diego Rolando Hernández-Galdamez, Miguel Ángel González-Block, Daniela Karola Romo-Dueñas, René Lima-Morales, Irma Alejandra Hernández-Vicente, Marivel Lumbreras-Guzmán, Pablo Méndez-Hernández
88 [GO] 2020―Jul―20 Response to: Amantadine, COVID-19 and Parkinsonism Gonzalo Emiliano Aranda-Abreu
89 [GO] 2020―Jul―03 Response to: Amantadine Treatment for People with COVID-19 Viroj Wiwanitkit
90 [GO] 2020―Jun―19 Targeting Cytokine Storm to Manage Patients with COVID-19: A Mini-Review Neda Roshanravan, Farhad Seif, Alireza Ostadrahimi, Mahboub Pouraghaei, Samad Ghaffari
91 [GO] 2020―Jun―18 Mapping the Changes on Incidence, Case Fatality Rates and Recovery Proportion of COVID-19 in Afghanistan Using Geographical Information Systems Sayed Hamid Mousavi, Shafi Ullah Zahid, Kalimullah Wardak, Kazim Ali Azimi, Sayed Mohammad Reza Hosseini, Marzia Wafaee, et al. (+6)
92 [GO] 2020―Jun―18 Molecular Alterations Prompted by SARS-CoV-2 Infection: Induction of Hyaluronan, Glycosaminoglycan and Mucopolysaccharide Metabolism Sergio Andonegui-Elguera, Keiko Taniguchi-Ponciano, Cesar Raul Gonzales-Bonilla, Javier Torres, Hector Mayani, Luis Alonso Herrera, et al. (+9)
93 [GO] 2020―Jun―12 Amantadine Treatment for People with COVID-19 Ramiro Araújo, José Dolores Aranda-Martínez, Gonzalo Emiliano Aranda-Abreu
94 [GO] 2020―Jun―12 Is Sexual Route a Matter of Concern for the SARS-CoV-2/COVID-19? Shailesh Kumar Patel, Mamta Pathak, Ranjit Sah, Akshay Kumar, Yashpal Singh Malik, Alfonso J. Rodríguez-Morales, Kuldeep Dhama
95 [GO] 2020―Jun―11 Laboratory Findings of COVID-19 Infection are Conflicting in Different Age Groups and Pregnant Women: A Literature Review Sina Vakili, Amir Savardashtaki, Sheida Jamalnia, Reza Tabrizi, Mohammad Hadi Nematollahi, Morteza Jafarinia, Hamed Akbari
96 [GO] 2020―Jun―07 Glucose 6 Phosphate Dehydrogenase Deficiency: An Actionable Risk Factor for Patients with COVID-19? Brenda Jamerson, Tirtadharyana Haryadi, Arline Bohannon
97 [GO] 2020―Jun―06 Covid-19 Sets off Mass Migration in India Richa Mukhra, Kewal Krishan, Tanuj Kanchan
98 [GO] 2020―Jun―06 Could Respiratory Fluoroquinolones, Levofloxacin and Moxifloxacin, Prove to be Beneficial as an Adjunct Treatment in COVID-19? Irene Karampela, Maria Dalamaga
99 [GO] 2020―May―31 Should we try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy? Solomon Habtemariam, Seyed fazel Nabavi, Maciej Banach, Ioana Berindan-Neagoe, Parames C. Sil, Seyed Mohammad Nabavi
100 [GO] 2020―May―30 Extensive Partnership, Collaboration, and Teamwork is Required to Stop the COVID-19 Outbreak Chiranjib Chakraborty, Ashish Ranjan Sharma, Garima Sharma, Manojit Bhattacharya, Rudra P. Saha, Sang-Soo Lee
101 [GO] 2020―May―30 SARS-CoV-2-A Tough Opponent for the Immune System Mahsa Golshani Nasab, Amene Saghazadeh, Nima Rezaei
102 [GO] 2020―May―25 Scientific Publications During the COVID-19 Pandemic Ana Carolina Sepúlveda-Vildósola, Juan Manuel Mejía-Aranguré, Carolina Barrera-Cruz, Natxieli Alexandra Fuentes-Morales, Carlos Rodriguez-Zeron
103 [GO] 2020―May―25 Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2 Sairaj Satarker, Madhavan Nampoothiri
104 [GO] 2020―May―22 Central Nervous System Involvement in COVID-19 Leila Jahanshahlu, Nima Rezaei
105 [GO] 2020―May―22 Defective Anti-oxidant System: An Aggravating Factor for COVID-19 Patients Outcome? Eva N. Kassi, Kostas A. Papavassiliou, Athanasios G. Papavassiliou
106 [GO] 2020―May―22 COVID-19: Situation of European Countries so Far Ehsanul Hoque Apu, Nazeeba Siddika, Sunitha Pillai, Russell Kabir
107 [GO] 2020―May―21 S1 Subunit and Host Proteases as Potential Therapeutic Avenues for the Treatment of COVID-19 Azher Arafah, Shafat Ali, Ali Mohd Yatoo, Md. Niamat Ali, Muneeb U. Rehman
108 [GO] 2020―May―21 Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19 Abinit Saha, Ashish Ranjan Sharma, Manojit Bhattacharya, Garima Sharma, Sang-Soo Lee, Chiranjib Chakraborty
109 [GO] 2020―May―21 Laboratory Biomarkers Predicting COVID-19 Severity in the Emergency Room Roberto Assandri, Elisabetta Buscarini, Ciro Canetta, Alessandro Scartabellati, Giovanni Viganò, Alessandro Montanelli
110 [GO] 2020―May―20 Covid-19 Pandemic and Current Medical Interventions Sweeta Manhas, Anjali Anjali, Sheikh Mansoor, Vikas Sharma, Ajaz Ahmad, Muneeb U. Rehman, Parvaiz Ahmad
111 [GO] 2020―May―20 Stigma Over COVID-19; New Conception Beyond Individual Sense Rahim Badrfam, Atefeh Zandifar
112 [GO] 2020―May―15 COVID-19 and Dysfunctional Endothelium: The Mexican Scenario Jose Antonio Alvarado-Moreno, Abraham Majluf-Cruz
113 [GO] 2020―May―13 COVID-19: Developing from an Outbreak to A Pandemic Sara Hanaei, Nima Rezaei
114 [GO] 2020―May―12 Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More Abinit Saha, Ashish Ranjan Sharma, Manojit Bhattacharya, Garima Sharma, Sang-Soo Lee, Chiranjib Chakraborty
115 [GO] 2020―May―06 Mysterious Virus: A Review on Behavior and Treatment Approaches of the Novel Coronavirus, 2019-nCoV Farshad Hemmati-Dinarvand, Samira Saedi, Mohsen Hemmati-Dinarvand, Marzie Zarei, Atefeh Seghatoleslam
116 [GO] 2020―Apr―30 A Review of Current Interventions for COVID-19 Prevention Deepak Pradhan, Prativa Biswasroy, Pradeep Kumar naik, Goutam Ghosh, Goutam Rath
117 [GO] 2020―Apr―30 Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) infection Livan Delgado-Roche, Fernando Mesta
118 [GO] 2020―Apr―29 COVID-19 and Moral Imperialism in Multinational Clinical Research Fernando Hellmann, Bryn Williams-Jones, Volnei Garrafa
119 [GO] 2020―Apr―29 Ongoing Challenges Faced in the Global Control of COVID-19 Pandemic Guillermo I. Perez Perez, Amin Talebi Bezmin Abadi
120 [GO] 2020―Apr―29 Sofosbuvir as Repurposed Antiviral Drug Against COVID-19: Why Were we Convinced to Evaluate the Drug in a Registered/Approved Clinical Trial? Babak Sayad, Mahsa Sobhani, Reza Khodarahmi
121 [GO] 2020―Apr―24 Tackling the COVID-19 Pandemic Farid Rahimi, Amin Talebi Bezmin Abadi
122 [GO] 2020―Apr―15 Bioactive Lipids and Coronavirus (COVID-19) Sora Yasri, Viroj Wiwanitkit
123 [GO] 2020―Apr―15 Reply to: Bioactive Lipids and Coronavirus (COVID-19)-further Discussion Undurti N. Das
124 [GO] 2020―Apr―15 Oleoylethanolamide, A Bioactive Lipid Amide, as A Promising Treatment Strategy for Coronavirus/COVID-19 Samad Ghaffari, Neda Roshanravan, Helda Tutunchi, Alireza Ostadrahimi, Mahboub Pouraghaei, Behnam Kafil
125 [GO] 2020―Apr―15 Comparative Global Epidemiological Investigation of SARS-CoV-2 and SARS-CoV Diseases Using Meta-MUMS Tool Through Incidence, Mortality, and Recovery Rates Massoud Sokouti, Ramin Sadeghi, Saeid Pashazadeh, Saeid Eslami, Mohsen Sokouti, Morteza Ghojazadeh, Babak Sokouti
126 [GO] 2020―Apr―15 Case-finding: Fast, Available, and Efficient Font-line Diagnostics for SARS-CoV-2 Farid Rahimi, Amin Talebi Bezmin Abadi
127 [GO] 2020―Apr―15 Global Threat of SARS-CoV-2/COVID-19 and the Need for More and Better Diagnostic Tools Mamta pathak, Shailesh kumar patel, Jigyasa rana, Ruchi tiwari, Kuldeep dhama, Ranjit sah, et al. (+3)
128 [GO] 2020―Apr―10 A Reusable Mask for Coronavirus Disease 2019 (COVID-19) Phan Thien Luan, Congo Tak-Shing Ching
129 [GO] 2020―Apr―04 Inappropriate Antibiotic Consumption as a Possible Cause of Inflammatory Storm and Septic Shock in Patients Diagnosed with Coronavirus-19 Disease (COVID-19) Sedigheh Hantoushzadeh, Amir Hossein Norooznezhad
130 [GO] 2020―Apr―04 Is the ACE2 Overexpression a Risk Factor for COVID-19 Infection? Abraham Edgar Gracia-Ramos
131 [GO] 2020―Mar―27 Can Bioactive Lipids Inactivate Coronavirus (COVID-19)? Undurti N. Das
132 [GO] 2020―Mar―27 Practical Strategies Against the Novel Coronavirus and COVID-19-the Imminent Global Threat Farid Rahimi, Amin Talebi Bezmin Abadi
 [1] 

132 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec